SHE/300723 (SHE/300723)

Shenzhen Stock Exchange: SHE/300723 · CNY

CN¥29.1

+0.35 (+1.2%)· Recorded snapshot

Market cap	13.1B
Revenue (ttm)	840.2M
Net income (ttm)	220.5M
EPS (ttm)	CN¥0.49
Shares out	448.5M
P/E (trailing)	59.7x
P/E (forward)	25.1x
Volume	2,711,481
Beta	0.75

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 840.2M
Net income (ttm): 220.5M
EPS (ttm): CN¥0.49
P/E (trailing): 59.7x
P/E (forward): 25.1x
Market cap: 13.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.1

P25 n/aP50 n/aP75 n/a

Trailing P/E59.7

P25 n/aP50 n/aP75 n/a

ROE11.4

P25 n/aP50 n/aP75 n/a

ROIC-12.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/300723 indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

CNY

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-30
Employees	1,294
Employees change	-190
Employees growth	-12.8%
Enterprise value	CNY 13.8B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2002
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE1000035J7
Last earnings date	2026-08-27
Last refreshed	2026-10-28
Last stock split date	2023-05-24
Last stock split type	Forward
Market cap	CNY 13.1B
Next earnings date	2026-10-30
Price	CNY 29.12
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	she/300723
Website	https://www.apichope.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	49.45x
Average P/E ratio (5Y)	64.47x
Earnings yield	1.68%
EV/Earnings	62.61x
EV/FCF	208.79x
EV/Sales	16.43x
FCF / EV yield	0.48%
FCF yield	0.51%
Forward P/E	25.1x
Graham number	6.7219
Graham upside	-76.92%
Industry forward P/E	17.34x
Industry P/E	33.74x
Lynch fair value	CNY 2.44
Lynch upside	-91.62%
P/B ratio	6.95x
P/E ratio	59.66x
P/FCF ratio	197.57x
P/OCF ratio	82.36x
P/S ratio	15.55x
Price / tangible book value	8.84x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-38.51%
EBITDA margin	-16.03%
FCF margin	7.87%
Gross margin	54.47%
Operating margin	-38.51%
Pretax margin	21.69%
Profit margin	26.24%
Profit per employee	CNY 170,380
Revenue per employee	CNY 649,297
ROA	-4.27%
ROA (5Y)	0.91%
ROCE	-9.99%
ROE	11.38%
ROE (5Y)	-2.03%
ROIC	-12.35%
ROIC (5Y)	1.53%
Tax / revenue	-3.69%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth 3Y	-14.39%
EPS growth 5Y	-4.22%
EPS growth quarters	4
EPS growth years	1
FCF growth (QoQ)	1,380.86%
FCF growth 3Y	-18.73%
Gross profit growth	-17.5%
Gross profit growth (Q)	-74.82%
Gross profit growth 3Y	-41.16%
Gross profit growth 5Y	-22.74%
Net income growth 3Y	-13.53%
Net income growth 5Y	-3.47%
Net income growth quarters	4
Net income growth years	1
OCF growth (QoQ)	307.4%
OCF growth 3Y	-32.28%
OCF growth 5Y	-10.69%
Revenue growth	-25.08%
Revenue growth (Q)	-48.63%
Revenue growth (QoQ)	-72.44%
Revenue growth 3Y	-31.73%
Revenue growth 5Y	-15.74%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -92.5M
Depreciation and amortization	CNY 188.9M
EBIT	CNY -323.6M
EBITDA	CNY -134.7M
EPS	CNY 0.49
FCF per share	CNY 0.15
Financing cash flow	CNY -984.7M
Free cash flow	CNY 66.1M
Gross profit	CNY 457.7M
Income taxes	CNY -31M
Investing cash flow	CNY 1.1B
Net borrowing	CNY -412M
Net cash flow	CNY 265.7M
Net income	CNY 220.5M
Operating income	CNY -323.6M
Revenue	CNY 840.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.26
Book value per share	CNY 4.11
Debt / equity	1.09
Debt / FCF	31.05
Goodwill	CNY 255,936
Interest coverage	-5.95
Long-term assets	CNY 2.6B
Long-term liabilities	CNY 1.4B
Net cash (debt)	CNY -707.4M
Net cash / market cap	-5.42%
Net debt / equity	0.38
Net debt / FCF	10.7
Piotroski F-Score	5
Property, plant and equipment	CNY 1.7B
Shareholders' equity	CNY 1.9B
Tangible book value	CNY 1.5B
Tangible book value per share	CNY 3.29
Total assets	CNY 4.5B
Total cash	CNY 1.3B
Total debt	CNY 2.1B
Total liabilities	CNY 2.6B
WACC	7.5%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.18
Current assets	CNY 1.9B
Current liabilities	CNY 1.2B
Current ratio	1.49
Inventory turnover	1.51
Net working capital	CNY 88.2M
Quick ratio	1.26
Working capital	CNY 607.3M
Working capital turnover	1.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.02%
Dividend growth (3Y)	-4.45%
Dividend growth (5Y)	10.13%
Dividend per share	CNY 0.00
Last dividend	CNY 0.21
Payout ratio	37.15%
Shareholder yield	0.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 36.05
1D price change	1.22%
1M price change	-12.29%
1M total return	-12.29%
1W price change	-5.64%
1W total return	-5.64%
1Y price change	-44.67%
1Y return CAGR	-44.69%
1Y total return	-44.67%
20-day SMA	CNY 31.45
200-day SMA	CNY 35.67
3M price change	-16.94%
3M total return	-16.94%
3Y price change	3.01%
3Y return CAGR	1.31%
3Y total return	3.97%
50-day SMA	CNY 34.12
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 56.88
52-week high date	2025-10-31
52-week low	CNY 28.41
52-week low date	2026-10-23
5Y price change	39.82%
5Y return CAGR	7.38%
5Y total return	42.72%
6M price change	-23.95%
6M total return	-23.95%
All-time high	CNY 81.48
All-time high date	2025-08-01
All-time low	CNY 7.58
All-time low date	2017-11-16
Average true range (ATR)	CNY 1.25
Average volume	3.6M
Beta (1Y)	0.67
Beta (2Y)	0.45
Beta (5Y)	0.75
Change from 52-week high	-48.8%
Change from 52-week low	2.5%
Change from all-time high	-64.26%
Change from all-time low	284.27%
Change from open	0.48%
Day's gap	0.73%
Dollar volume	CNY 79M
High price	CNY 29.41
Low price	CNY 28.76
Monthly RSI	44.4
Open price	CNY 28.98
Position in 52-week range	55.38%
Previous close	CNY 28.77
Price vs 150-day SMA	-19.22%
Price vs 20-day SMA	-7.41%
Price vs 200-day SMA	-18.35%
Price vs 50-day SMA	-14.64%
Relative volume	0.75
RSI	32.92
Sharpe ratio	-0.75
Sharpe ratio (3Y)	0.48
Sharpe ratio (5Y)	0.29
Sortino ratio	-0.99
Sortino ratio (3Y)	0.88
Sortino ratio (5Y)	0.58
Volume	2.7M
Weekly RSI	36.25
YTD price change	-13.2%
YTD total return	-13.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	160.1M
Shares change (QoQ)	0.01%
Shares change (YoY)	-0.02%
Shares held by insiders	21.15%
Shares held by institutions	10.11%
Shares outstanding	448.5M

Deeper analysis on SHE/300723

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/300723 report

Is a complete SHE/300723 research report available?

No complete published report is available for she/300723 (SHE/300723) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/300723 (SHE/300723)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300723

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300723 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300723

Frequently asked questions